Quantcast
Home / Practice Areas / Business and Civil Practice / Pfizer to pay $142.1 million over marketing of epilepsy drug

Pfizer to pay $142.1 million over marketing of epilepsy drug

Pfizer, the drug maker, has been ordered to pay a total of $142.1 million in damages for violating federal racketeering laws in the marketing of its epilepsy drug Neurontin.